Latest Data & Signals Issued

Signal Type Signal Value Data
Score 1.679 12 days ( -5.18 % )
Last Price $22.14 -2.60 %
High/ Low $21.85 - $22.98 4.21%
Chg 7 Days -0.717 % $22.30 $22.14
Chg 30 Days 2.93 % $21.51 $22.14
Chg 12 mos -17.70 % $26.90 $22.14
Trend - 3 mos 15.14 % Width: 40.52 %
Trend - 12 mos -32.31 % Width: 101.11 %
Pred. range - 3 mos $21.95 - $30.84 -0.86 % - 39.31 %
Pred. range - 12 mos $9.18 - $18.47 -58.52 % - -16.59 %
Short MA avg 3 mos Sell Dec 03, 2024 - 8 days
Long MA avg 3 mos Buy Nov 25, 2024 - 13 days
Short/Long MA avg 3 mos Buy Nov 27, 2024 - 11 days
Short MA avg 12 mos Buy Nov 25, 2024 - 13 days
Long MA avg 12 mos Buy Nov 26, 2024 - 12 days
Short/Long MA avg 12 mos Sell Aug 22, 2024 - 79 days
Pivot Short Sell Dec 02, 2024 - 9 days
Bollinger Buy Nov 15, 2024 - 19 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT ARROWHEAD RESEARCH CORPORATION
Arrowhead Research
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P...
GOLDEN STAR
Ticker Change Signal Date
FCFS
$106.38
2.09% Dec 09
C
COMT
$25.98
1.35% Dec 09
I
IBTF
$23.31
0.0764% Dec 09
ACN
$358.29
0.536% Dec 05
V
VGSH
$58.28
0.0343% Dec 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE